scholarly journals Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy

2013 ◽  
Vol 24 (3) ◽  
pp. 222 ◽  
Author(s):  
Tatsuya Kato ◽  
Hidemichi Watari ◽  
Mahito Takeda ◽  
Masayoshi Hosaka ◽  
Takashi Mitamura ◽  
...  
Keyword(s):  
Uterine Cervix ◽  
Radical Hysterectomy ◽  
Systematic Lymphadenectomy ◽  
Prognostic Analysis

Radical Hysterectomy for Recurrent Carcinoma of the Uterine Cervix after Radiotherapy

1994 ◽  
Vol 55 (1) ◽  
pp. 29-35 ◽  
Author(s):  
Robert L. Coleman ◽  
Elden D. Keeney ◽  
Ralph S. Freedman ◽  
Thomas W. Burke ◽  
Patricia J. Eifel ◽  
...  
Keyword(s):  
Uterine Cervix ◽  
Radical Hysterectomy ◽  
Recurrent Carcinoma

Comparison of the Prognoses of FIGO Stage I to Stage II Adenosquamous Carcinoma and Adenocarcinoma of the Uterine Cervix Treated With Radical Hysterectomy

2012 ◽  
Vol 22 (8) ◽  
pp. 1389-1397 ◽  
Author(s):  
Seiji Mabuchi ◽  
Mika Okazawa ◽  
Yasuto Kinose ◽  
Koji Matsuo ◽  
Masateru Fujiwara ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cervical Cancer ◽  
High Risk ◽  
Uterine Cervix ◽  
Radical Hysterectomy ◽  
Adenosquamous Carcinoma ◽  
Early Stage ◽  
Univariate Analysis ◽  
Low Risk ◽  
Histological Subtype

ObjectivesTo evaluate the significance of adenosquamous carcinoma (ASC) compared with adenocarcinoma (AC) in the survival of surgically treated early-stage cervical cancer.MethodsWe retrospectively reviewed the medical records of 163 patients with International Federation of Gynecology and Obstetrics stage IA2 to stage IIB cervical cancer who had been treated with radical hysterectomy with or without adjuvant radiotherapy between January 1998 and December 2008. The patients were classified according to the following: (1) histological subtype (ASC group or AC group) and (2) pathological risk factors (low-risk or intermediate/high-risk group). Survival was evaluated using the Kaplan-Meier method and compared using the log-rank test. Multivariate analysis of progression-free survival (PFS) was performed using the Cox proportional hazards regression model to investigate the prognostic significance of histological subtype.ResultsClinicopathological characteristics were similar between the ASC and AC histology groups. Patients with the ASC histology displayed a PFS rate similar to that of the patients with the AC histology in both the low-risk and intermediate/high-risk groups. Neither the recurrence rate nor the pattern of recurrence differed between the ASC group and the AC group. Univariate analysis revealed that patients with pelvic lymph node metastasis and parametrial invasion achieved significantly shorter PFS than those without these risk factors.ConclusionsCharacteristics of the patients and the tumors as well as survival outcomes of ASC were comparable to adenocarcinoma of early-stage uterine cervix treated with radical hysterectomy. Our results in part support that the management of ASC could be the same as the one of AC of the uterine cervix.

scholarly journals Primary malignant melanoma of the uterine cervix treated with radical surgery and adjuvant chemo-radiation using temozolomide and cisplatin: a case report

2019 ◽  
Vol 8 (8) ◽  
pp. 3387
Author(s):  
Goter Doke ◽  
Shyam Tsering ◽  
Hage Nobin ◽  
Dacto Gara
Keyword(s):  
Case Report ◽  
Malignant Melanoma ◽  
Uterine Cervix ◽  
Radical Hysterectomy ◽  
Vaginal Bleeding ◽  
Radical Surgery ◽  
Pelvic Lymphadenectomy ◽  
Primary Malignant Melanoma ◽  
Rare Neoplasm

Primary malignant melanoma of the uterine cervix is a rare neoplasm and the overall prognosis of patients with this disease is very poor. Herein, authors report a case of 45-year-old woman who presented with vaginal bleeding for one months and examination showed an exophytic, 6 cm polypoid blackish-pigmented tumor on the cervix involving vaginal fornix. She underwent abdominal radical hysterectomy with bilateral salpingo-oophorectomy and pelvic lymphadenectomy and further received adjuvant concurrent chemo-radiation with cisplatin (CDDP) and temozolamide but died 7 months after surgery.

scholarly journals Small cell carcinoma of the uterine cervix during pregnancy

Rare Tumors ◽  
2019 ◽  
Vol 11 ◽  
pp. 203636131986653 ◽  
Author(s):  
Satoshi Eto ◽  
Kentaro Kai ◽  
Kaei Nasu ◽  
Masakazu Nishida ◽  
Haruto Nishida ◽  
...  
Keyword(s):  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Uterine Cervix ◽  
Radical Hysterectomy ◽  
Early Stage ◽  
Pelvic Lymphadenectomy ◽  
Japanese Woman ◽  
Small Cell ◽  
Definitive Therapy ◽  
Distant Spread

Small cell carcinoma of the uterine cervix is a rare histological entity that has a poor prognosis. We report the case of a patient with small cell carcinoma of the uterine cervix who underwent a radical hysterectomy during pregnancy. A 33-year-old Japanese woman with genital bleeding was referred at 15 weeks’ gestation. A speculum exam revealed a 5.4-cm-dia. mass in the cervix, and a cervical biopsy revealed small cell carcinoma of the uterine cervix. Imaging studies demonstrated a tumor confined to the cervix, swelling of intra-pelvic lymph nodes, and no distant spread of the tumor. She was diagnosed as having small cell carcinoma of the uterine cervix, stage IB2, and underwent a radical hysterectomy with pelvic lymphadenectomy. She refused any adjuvant therapies, had a systemic relapse 4 months after surgery, and died of the disease 5 months after surgery. Early-stage small cell carcinoma of the uterine cervix should be treated with a definitive therapy soon after diagnosis whether the patient is pregnant or not. Saving the mother’s life should be the top priority.

Sign in / Sign up

Export Citation Format

Share Document